http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021528371-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6093
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-3344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G81-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64
filingDate 2019-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021528371-A
titleOfInvention Compositions and Methods for Immune Tolerance
abstract The present disclosure provides a composition comprising a mannose fusion antigen that targets the mannose receptor. The composition can be used to prevent immunity to a protein-based drug that would otherwise elicit an immune response, or to reduce the immune response to the drug.
priorityDate 2018-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467665941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467665942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163594111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465203501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466497398

Total number of triples: 40.